Obalon Therapeutics gets $30m for weight-loss balloon

Obalon Therapeutics secures $30 million to fund development of its ingestible weight-loss device, the Obalon balloon.

Obalon Therapeutics said it secured $30 million to fund development of its ingestible weight-loss device, the Obalon balloon.

Obalon Therapeutics

News Well, Bariatrics, Venture Capital/Private Equity, Weight loss

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BwloQK